[144] Olema Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Olema Pharmaceuticals (OLMA) filed a Form 144 proposing the sale of 13,086 common shares. The sale is to be executed through Fidelity Brokerage Services with an approximate aggregate market value of $108,977.56 and an intended sale date of 09/18/2025. The company reports 68,634,329 shares outstanding, making the proposed sale a small portion of outstanding stock. The filer acquired 10,000 shares as founders shares on 03/20/2007 (compensation) and 3,086 shares in an open-market purchase on 06/30/2014 (cash). The filing also discloses recent sales on 09/16/2025: 10,000 shares by Cyrus L. Harmon for $80,362.60 and 1,914 shares by Harmon Family Investors LLC for $15,464.28. The filer certifies no undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Insider sale is immaterial relative to outstanding shares and unlikely to move valuation.

The Form 144 notifies the market of a proposed sale of 13,086 common shares valued at about $109k against 68.6 million shares outstanding, representing roughly 0.019% of the float. The filing documents the original acquisition dates and payment methods, clarifying these are not recent compensatory grants except for long-held founder shares. Recent reported sales on 09/16/2025 provide execution context. From a capital-markets perspective, the size and timing indicate routine disposition rather than a material corporate development.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; no governance red flags evident in the form.

The notice includes required details: broker, number of shares, aggregate value, acquisition history, and prior sales in the three-month lookback. The signer affirms absence of undisclosed material information and references compliance with trading-plan language. There are no indications of unusual selling patterns or related-party complications in the provided data. This filing appears to be a routine insider sale disclosure under securities rules.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13086	108977.56	68634329	09/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/20/2007	Founders Shares	Issuer			10000	03/20/2007	Compensation
Common	06/30/2014	Open Market Purchase	Issuer			3086	06/30/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Cyrus L. Harmon 780 Brannan Street San Francisco CA 94103	Common	09/16/2025	10000	80362.60
Harmon Family Investors Llc 780 Brannan Street San Francisco CA 94103	Common	09/16/2025	1914	15464.28

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for OLMA disclose about the proposed sale?

The Form 144 proposes selling 13,086 common shares through Fidelity with an aggregate market value of $108,977.56, targeting 09/18/2025.

How many OLMA shares are outstanding according to the filing?

The filing reports 68,634,329 shares outstanding.

What is the acquisition history of the shares to be sold?

The filer acquired 10,000 shares as founder shares on 03/20/2007 (compensation) and 3,086 shares via open-market purchase on 06/30/2014 (cash).

Were there any sales of OLMA securities in the past three months disclosed?

Yes. On 09/16/2025, Cyrus L. Harmon sold 10,000 shares for $80,362.60 and Harmon Family Investors LLC sold 1,914 shares for $15,464.28.

Does the filer state there is any undisclosed material information?

The filer represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.